Recent News Stories

Mon, Nov 03, 2014 - 06:35
The results of the National Viral Hepatitis Roundtable Steering Committee election have been announced.
Wed, Oct 29, 2014 - 13:57
NVHR has endorsed S.2839, the Comprehensive Addiction and Recovery Act of 2014.
Tue, Sep 16, 2014 - 15:34
NVHR held a webinar featuring Dr. Cami Graham, Co-Director, Viral Hepatitis Center, Division of Infectious Diseases at Beth Israel Deaconess Medical Center on why and how to make the case for the importance and urgency of screening baby boomers (those born 1945-1965) for hepatitis C. We also shared information about how NVHR's educational program offers resources for implementing screening and linkage to care programs in your health care setting or community.
Wed, Sep 10, 2014 - 08:40
Leaders in the hepatitis C community urge HHS Secretary Burwell to take leadership in addressing barriers to lifesaving treatment.
Tue, Aug 19, 2014 - 07:30
Learn more about Christine Rodriguez, NVHR's new Public Policy Manager
 
 
 
 

Recent Posts

Tue, Aug 19, 2014 - 08:08
NVHR has created a fact sheet about The Viral Hepatitis Testing Act of 2014 (S. 2538). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tue, Aug 19, 2014 - 08:07
NVHR has developed a fact sheet about The Viral Hepatitis Testing Act of 2013 (H.R. 3723). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tue, Jul 29, 2014 - 13:58
People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen plus ribavirin, resulting in a 97% cure rate, according to a report this week at the 20th International AIDS Conference in Melbourne.
Tue, Jul 29, 2014 - 13:56
The hepatitis C virus (HCV) World Community Advisory Board (CAB) grew from an international AIDS activist movement. The objectives of the meeting were threefold: To provide a forum for leading activists to learn about developments in HCV treatment and access barriers; To find common advocacy strategies; and To meet with pharmaceutical companies about their plans for low- and middle-income countries (LMICs).
Tue, Jul 29, 2014 - 13:48
The importance of integrating people who inject drugs into HCV treatment programs. Arguments from a public health and human rights perspective. This document develops core arguments for why it is relevant, feasible, and indeed crucial to include people who inject drugs in national treatment guidelines and programs for chronic HCV infection – from both public health and human rights perspectives.
 
 
 
 
member logos
Banner2
Banner1
member logos
member logos
taskforce
Asoicacion Puertorriquenos en Marche (APM)
slide 12